Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Hamad Alam
Rectal Adenocarcinoma
New Delhi
Hamad’s struggle reached a terrifying peak in 2018 while traveling back to Delhi from a cou…
Shilipi
Acute Recurrent Pancreatitis
Kotdwar, Uttarakhand.
Shilpi’s struggle began suddenly during her 10th-grade school break, when she felt a sharp …
Anurag Goyal
Investment Banker
New Delhi
Anurag’s struggle began suddenly in the midnight of September 2010, when he experienced exc…
Sumit Kumar
Pancreas Divisum with secondary Chronic Pancreatitis
Dehradun, Uttarakhand
Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…
Aviral Saxena
Chronic Pancreatitis with Secondary Diabetes
Dehradun, Uttarakhand
Aviral’s journey began in November 2022 while he was actively working as a freelancer. The …
Rajeev Sharma
Chronic Pancreatitis
Dehradun, Uttarakhand
Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Randomized Controlled Study to Evaluate Prophylactic Properties of Ayurvedic Treatment Protocol in Refractory and Chronic Migraine Patients
This study compared Ayurvedic treatment to conventional therapy for chronic refractory migraine. After 360 days, the Ayurvedic group showed greater reductions in headache days, VAS, and MIDAS scores (p
Observational research on the effect of an Ayurvedic treatment protocol in patients of hereditary pancreatitis
Hereditary pancreatitis (HP) is a chronic genetic disorder with limited treatment options. This study evaluated the efficacy of a year-long Ayurvedic Treatment Protocol (ATP) in 151 patients, 88 of whom completed the program. The treatment included Ayurvedic formulations, dietary adjustments, and discontinuation of pancreatic enzymes. Results showed a 92.8% reduction in attack frequency and a 98.7% decrease in hospitalizations (p < 0.0001), with no adverse effects. ATP demonstrated safety and effectiveness in managing HP, suggesting the need for further research.
Clinical Intervention of Ayurvedic Treatment in the Patients of Recurrent Acute/Chronic Pancreatitis
The study of 1233 acute pancreatitis patients found that 12.9% experienced oral feeding intolerance (OFI). Risk factors included younger age, male sex, alcohol use, smoking, non-biliary etiology, and SIRS at 48h. SIRS at 48h (OR 2.85) and non-biliary etiology (OR 1.77) were independently linked to OFI, with biliary etiology being protective.
Management of multi-relapsed chronic pancreatitis through Rasaushadhis: A case study
Chronic pancreatitis causes irreversible pancreatic damage with limited treatment success and significant mortality. This case highlights a patient managed with Ayurveda, achieving nine years symptom-free and no disease progression.
Response to Ayurvedic therapy in the treatment of migraine without aura
A study on 204 migraine patients using an Ayurvedic Treatment Protocol (AyTP) showed 35.2% had complete relief, 35.2% had mild episodes without medication, and 70.5% experienced reduced pain frequency and intensity. The preliminary results suggest the AyTP may be effective, though the study's design limits firm conclusions.
Scientific validated approach for application of Mandura bhasma A review
Mandura (iron rust) is purified and calcined in Ayurveda to create Mandura Bhasma, used for conditions like spleen and liver enlargement, jaundice, oedema, and anemia. Our study found that Prak-20 aligns with the classical dose schedule for Mandura Bhasma.